Summery_2022_11

According to the Digest`s Editorial office opinion, the main events of the November 2022 in Russian pharmaceutical industry are:

- in Russia, antimicrobial resistance is considered as a state biological threat factor;

- the police have uncovered a scheme of illegal online trade in expensive medicines;

- The Russian Ministry of Health has developed requirements for off-label medicines;

- the management of GSK in Russia has offered all employees to quit;

- the regulator has identified dangerous falsified medicines for animals.

These, as well all other industry month news, are in the November 2022 issue (Russian edition) of the Digest.

Best regards,

Natalia Egorova, Editor-in-Chief

01.12.2022.